ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Bigdaddio
|
89 |
47K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
89
|
47K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
Bigdaddio
|
62 |
20K |
3 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
62
|
20K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Jane Bell Appointed Chair of Audit and Risk Committee
|
|
Bigdaddio
|
65 |
24K |
4 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
65
|
24K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Bigdaddio
|
574 |
193K |
7 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
193K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Bigdaddio
|
574 |
193K |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
193K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2023 Full Year Financial Results Webcast
|
|
Bigdaddio
|
60 |
29K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Bigdaddio
|
904 |
277K |
10 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
904
|
277K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Bigdaddio
|
904 |
277K |
2 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
904
|
277K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Bigdaddio
|
904 |
277K |
3 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
904
|
277K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Bigdaddio
|
904 |
277K |
15 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
904
|
277K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
******************* Mesoblast Limited (MSB) Chart ********************
|
|
Bigdaddio
|
8 |
4.1K |
1 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
8
|
4.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bigdaddio
|
116 |
35K |
11 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
116
|
35K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Survival Outcomes in COVID-19 ARDS Patients
|
|
Bigdaddio
|
70 |
25K |
14 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
70
|
25K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Bigdaddio
|
17K |
6.6M |
4 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
Bigdaddio
|
408 |
123K |
11 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
408
|
123K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Bigdaddio
|
5.2K |
2.6M |
5 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
5.2K
|
2.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Bigdaddio
|
850 |
250K |
2 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
250K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Bigdaddio
|
850 |
250K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
250K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Novartis countdown
|
|
Bigdaddio
|
373 |
112K |
1 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
373
|
112K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Bigdaddio
|
17K |
6.6M |
10 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
17K
|
6.6M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
Bigdaddio
|
1.5K |
413K |
3 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.5K
|
413K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
Bigdaddio
|
57 |
23K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
57
|
23K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
Bigdaddio
|
57 |
23K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
57
|
23K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Novartis tomorrow bout time
|
|
Bigdaddio
|
57 |
23K |
5 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
57
|
23K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
Bigdaddio
|
1.6K |
463K |
1 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
463K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
Bigdaddio
|
177 |
57K |
23 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
177
|
57K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
Bigdaddio
|
422 |
143K |
5 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
143K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Novartis - Heart Failure - Primary Endpoints
|
|
Bigdaddio
|
100 |
27K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
100
|
27K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Bigdaddio
|
5.2K |
2.6M |
0 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
5.2K
|
2.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Bigdaddio
|
17K |
6.6M |
9 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Why Meso is pumping today?
|
|
Bigdaddio
|
109 |
43K |
6 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
109
|
43K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Bigdaddio
|
93 |
35K |
6 |
30/01/21 |
30/01/21 |
ASX - By Stock
|
93
|
35K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Bigdaddio
|
93 |
35K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
93
|
35K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Bigdaddio
|
93 |
35K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
93
|
35K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Bigdaddio
|
93 |
35K |
12 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
93
|
35K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB Video channel'
|
|
Bigdaddio
|
56 |
20K |
5 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
56
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Partnerships vs FDA
|
|
Bigdaddio
|
63 |
25K |
4 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
63
|
25K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Bigdaddio
|
10K |
3.0M |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Partnerships vs FDA
|
|
Bigdaddio
|
63 |
25K |
10 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
63
|
25K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
Bigdaddio
|
255 |
83K |
2 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
255
|
83K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
Bigdaddio
|
221 |
66K |
3 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
221
|
66K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Bigdaddio
|
1.0K |
501K |
3 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
1.0K
|
501K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Bigdaddio
|
1.0K |
501K |
8 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
1.0K
|
501K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Bigdaddio
|
763 |
324K |
1 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Bigdaddio
|
763 |
324K |
1 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Bigdaddio
|
10K |
3.0M |
7 |
17/01/21 |
17/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Bigdaddio
|
1.0K |
501K |
5 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
1.0K
|
501K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Bigdaddio
|
1.0K |
501K |
4 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
1.0K
|
501K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Bigdaddio
|
1.0K |
501K |
9 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
1.0K
|
501K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Healthcare Conference Investor Presentation
|
|
Bigdaddio
|
73 |
41K |
1 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
73
|
41K
|
1
|
|